RESEARCH TRIANGLE PARK, N.C. , April 13, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it has entered into a common stock purchase agreement with certain institutional, accredited investors for the private placement of 8,626,037 shares of common stock at a

RESEARCH TRIANGLE PARK, N.C. , April 07, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Damian deGoa, Chief Executive Officer of Liquidia , will provide an overview and update on the company's business during a fireside chat session at the 20th Annual Needham

Addressable market for generic Treprostinil Injection more than doubles FDA cleared 510(k) for RG 3ml Medication Cartridge for use with CADD-MS® 3 pump RESEARCH TRIANGLE PARK, N.C. , March 30, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced

-  Integrated RareGen (now known as Liquidia PAH) to establish commercial presence in PAH -  Clarified path towards submitting response to CRL for LIQ861 in mid-2021 -  Reducing net annual spending more than 40% in 2021 compared to 2020 cash burn -  Company to host webcast and conference call today

RESEARCH TRIANGLE PARK, N.C. , March 09, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that 2020 financial results will be reported on Tuesday, March 23, 2021 . The company will host a webcast and conference call at 8:30 a.m.

RESEARCH TRIANGLE PARK, N.C. , March 02, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced the closing of a debt facility on February 26, 2021 , with Silicon Valley Bank , which provides Liquidia with up to $20.5 million in term loans of which the first $10.5 million was

RESEARCH TRIANGLE PARK, N.C. , Dec. 14, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Damian deGoa has been appointed as Chief Executive Officer (CEO) and a director of the Company, effective immediately. He succeeds Neal F.

RESEARCH TRIANGLE PARK, N.C. , Nov. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Michael Kaseta has been appointed Chief Financial Officer (CFO), effective immediately. He succeeds Steve Bariahtaris who has served as Liquidia’s interim CFO since August 2020 . Mr.

CRL does not cite need for additional clinical studies CRL focuses on drug CMC and device biocompatibility   information Conference Call Scheduled for Today at 9:00a . m . ET RESEARCH TRIANGLE PARK, N.C. , Nov. 25, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc.

Merger   Reinforc es Company’s Commitment to Patients with PAH Paul Manning and Roger Jeffs Join Liquidia Corporation Board of Directors RESEARCH TRIANGLE PARK, N.C. , Nov. 18, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage clinical biopharmaceutical company